Myriad Genetics, Inc.MYGNNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank93
3Y CAGR+7.1%
5Y CAGR+6.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+7.1%/yr
vs +0.1%/yr prior
5Y CAGR
+6.8%/yr
Consistent
Acceleration
+6.9pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$247.90M-1.7%
2024$252.20M+6.8%
2023$236.20M+16.9%
2022$202.00M+2.2%
2021$197.60M+10.9%
2020$178.20M-4.2%
2019$186.10M-7.4%
2018$201.00M+13.4%
2017$177.20M+3.5%
2016$171.20M-